News & Events

Northern New England Clinical and Translational Research (NNE-CTR) successes, events and news.


  • Class of '21 Public Health Projects Poster Session & Celebration 1/23/19
    Our Class of 2021 presents their public health projects in the annual Poster Session & Community Celebration on January 23 from 3:30 to 5:30 in the Hoehl Gallery.
  • Funding Opp: Genetics & Phenotypes Associated with Drug Abuse
    The goals of this initiative are to discover allelic variants, genomic alterations, and functional changes associated with addictive behaviors in non-human animals through systems studies that employ genetic and genomics strategies. We also encourage applications that take genetic and/or genomics approaches to integrate data, delineate gene networks, and uncover the function of known or newly discovered genetic or epigenetic variants.
  • Funding Opp: RFA-OD-19-014 for NIH REACH Awards
    This FOA announces the renewal of the NIH Research Evaluation and Commercialization Hub (REACH) program, established to facilitate and accelerate the translation of academic biomedical discoveries into products that improve patient care and public health. Through this program, NIH will provide the qualifying institutions with the funds to seed the creation of academic entrepreneurship Hubs.
  • Round 3 Pilot Project LOIs Invited to Submit Full Proposals
    The Pilot Project Program of the Northern New England Clinical & Translational Research Network issued a request for Letters of Intent (LOIs) for potential study funding on October 26th. These one-year grants will be awarded to proposals that have a highly significant impact through novel approaches that can ultimately improve healthcare to at-risk populations. The NNE-CTR is particularly interested in pilot studies addressing: addiction medicine, cancer, cardiovascular disease, and healthcare issues relevant to rural and aging communities. Full Proposal invitees have been notified of the January 18, 2019 due date.
  • RNAscope Technology presented by Microscopy Imaging Center
    RNAscope is an RNA in situ detection platform. The RNAscope® Assays are based on the proprietary RNAscope® Technology, enabling RNA target expression analysis within intact cells and tissues with high sensitivity and specificity. The innovative RNAscope® Assay, with in situ hybridization technology to detect mRNA and ncRNA targets of >300bp, was launched in 2011 and marks the foundation of our product portfolio. The proprietary probe design requires an average of 20 Z pairs per target, however a minimum hybridization of 6 Z pairs can be used to obtain a signal. With over 1,400 publications in peer-reviewed journals, across multiple disciplines, the RNAscope® Assay represents a revolutionary advance in in situ target RNA detection. The seminar highlighted the basis of RNAscope technology and labeling protocols, including troubleshooting tips and examples of labeling with both chromogenic and fluorescent dyes.
  • Opioid Prescribing Study of the NNE-CTR Profiled in VT Digger
    Click on the title for a link to access article.
  • New NNE-CTR Funding to Support Community Engagement Approach to Study Opioid Prescribing
    An innovative initiative that will use a public health approach to inform opioid prescribing policies will be launched in northern New England thanks to a new $339,000 grant to the Northern New England Clinical and Translational Research (NNE-CTR) Network from the National Institutes of Health.
  • Pilot Project LOIs Propose Cancer-Related Studies
    In its first year of accepting grant requests, the Pilot Project Program of the Northern New England Clinical & Translational Research Network received nearly 60 Letters of Intent (LOIs) for potential study funding.  A handful in each of the first two rounds highlighted cancer-related aims. Due to limited funding, only the most fully-developed programs were approved, while others were encouraged to further develop and resubmit in future rounds.
  • Round 1 Pilot Project Awardees Announced
    After careful peer review of 34 applications submitted in November 2017, we are pleased to announce the five Round 1 Northern New England Clinical & Translational Research Network pilot project award winners.

Additional Highlights